245 related articles for article (PubMed ID: 29254242)
21. Unraveling obscurins in heart disease.
Grogan A; Kontrogianni-Konstantopoulos A
Pflugers Arch; 2019 May; 471(5):735-743. PubMed ID: 30099631
[TBL] [Abstract][Full Text] [Related]
22. BRCA-Pathway: a structural integration and visualization system of TCGA breast cancer data on KEGG pathways.
Kim I; Choi S; Kim S
BMC Bioinformatics; 2018 Feb; 19(Suppl 1):42. PubMed ID: 29504910
[TBL] [Abstract][Full Text] [Related]
23. Enhancer RNA SLIT2 Inhibits Bone Metastasis of Breast Cancer Through Regulating P38 MAPK/c-Fos Signaling Pathway.
Li P; Lin Z; Liu Q; Chen S; Gao X; Guo W; Gong F; Wei J; Lin H
Front Oncol; 2021; 11():743840. PubMed ID: 34722297
[TBL] [Abstract][Full Text] [Related]
24. Interaction of the Wnt/β-catenin and RAS-ERK pathways involving co-stabilization of both β-catenin and RAS plays important roles in the colorectal tumorigenesis.
Lee SK; Hwang JH; Choi KY
Adv Biol Regul; 2018 May; 68():46-54. PubMed ID: 29449169
[TBL] [Abstract][Full Text] [Related]
25. Structural analysis of obscurin gene in hypertrophic cardiomyopathy.
Arimura T; Matsumoto Y; Okazaki O; Hayashi T; Takahashi M; Inagaki N; Hinohara K; Ashizawa N; Yano K; Kimura A
Biochem Biophys Res Commun; 2007 Oct; 362(2):281-7. PubMed ID: 17716621
[TBL] [Abstract][Full Text] [Related]
26. Machine learning assisted analysis of breast cancer gene expression profiles reveals novel potential prognostic biomarkers for triple-negative breast cancer.
Thalor A; Kumar Joon H; Singh G; Roy S; Gupta D
Comput Struct Biotechnol J; 2022; 20():1618-1631. PubMed ID: 35465161
[TBL] [Abstract][Full Text] [Related]
27. Binding of an ankyrin-1 isoform to obscurin suggests a molecular link between the sarcoplasmic reticulum and myofibrils in striated muscles.
Bagnato P; Barone V; Giacomello E; Rossi D; Sorrentino V
J Cell Biol; 2003 Jan; 160(2):245-53. PubMed ID: 12527750
[TBL] [Abstract][Full Text] [Related]
28. Identification of candidate cancer drivers by integrative Epi-DNA and Gene Expression (iEDGE) data analysis.
Li A; Chapuy B; Varelas X; Sebastiani P; Monti S
Sci Rep; 2019 Nov; 9(1):16904. PubMed ID: 31729402
[TBL] [Abstract][Full Text] [Related]
29. An Integrative Computational Approach Based on Expression Similarity Signatures to Identify Protein-Protein Interaction Networks in Female-Specific Cancers.
Pane K; Affinito O; Zanfardino M; Castaldo R; Incoronato M; Salvatore M; Franzese M
Front Genet; 2020; 11():612521. PubMed ID: 33424936
[TBL] [Abstract][Full Text] [Related]
30. p38β - MAPK11 and its role in female cancers.
Katopodis P; Kerslake R; Zikopoulos A; Beri N; Anikin V
J Ovarian Res; 2021 Jun; 14(1):84. PubMed ID: 34174910
[TBL] [Abstract][Full Text] [Related]
31. The Predictive and Prognostic Role of RAS-RAF-MEK-ERK Pathway Alterations in Breast Cancer: Revision of the Literature and Comparison with the Analysis of Cancer Genomic Datasets.
Rocca A; Braga L; Volpe MC; Maiocchi S; Generali D
Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358725
[TBL] [Abstract][Full Text] [Related]
32. Integrating Bioinformatics and Drug Sensitivity Analyses to Identify Molecular Characteristics Associated with Targeting Necroptosis in Breast Cancer and their Clinical Prognostic Significance.
Zheng C; Guo H; Mo Y; Liu G
Recent Pat Anticancer Drug Discov; 2023 Aug; ():. PubMed ID: 37653627
[TBL] [Abstract][Full Text] [Related]
33. Age-specific gene expression signatures for breast tumors and cross-species conserved potential cancer progression markers in young women.
Colak D; Nofal A; Albakheet A; Nirmal M; Jeprel H; Eldali A; Al-Tweigeri T; Tulbah A; Ajarim D; Malik OA; Inan MS; Kaya N; Park BH; Bin Amer SM
PLoS One; 2013; 8(5):e63204. PubMed ID: 23704896
[TBL] [Abstract][Full Text] [Related]
34. Dynamics of obscurin localization during differentiation and remodeling of cardiac myocytes: obscurin as an integrator of myofibrillar structure.
Borisov AB; Kontrogianni-Konstantopoulos A; Bloch RJ; Westfall MV; Russell MW
J Histochem Cytochem; 2004 Sep; 52(9):1117-27. PubMed ID: 15314079
[TBL] [Abstract][Full Text] [Related]
35. NALCN is a potential biomarker and therapeutic target in human cancers.
He J; Xu J; Chang Z; Yan J; Zhang L; Qin Y
Front Genet; 2023; 14():1164707. PubMed ID: 37152978
[No Abstract] [Full Text] [Related]
36. Comprehensive Analysis of RUNX and TGF-β Mediated Regulation of Immune Cell Infiltration in Breast Cancer.
Gao L; Zhou F
Front Cell Dev Biol; 2021; 9():730380. PubMed ID: 34485309
[TBL] [Abstract][Full Text] [Related]
37. Systematic identification of lincRNA-based prognostic biomarkers by integrating lincRNA expression and copy number variation in lung adenocarcinoma.
Wang L; Zhao H; Xu Y; Li J; Deng C; Deng Y; Bai J; Li X; Xiao Y; Zhang Y
Int J Cancer; 2019 Apr; 144(7):1723-1734. PubMed ID: 30226269
[TBL] [Abstract][Full Text] [Related]
38. Significant prognostic values of differentially expressed-aberrantly methylated hub genes in breast cancer.
Qi L; Zhou B; Chen J; Hu W; Bai R; Ye C; Weng X; Zheng S
J Cancer; 2019; 10(26):6618-6634. PubMed ID: 31777591
[No Abstract] [Full Text] [Related]
39. ATP6AP2 is Overexpressed in Breast Cancer and Promotes Breast Cancer Progression.
Zhao K; Wang M; Wu A
Cancer Manag Res; 2020; 12():10449-10459. PubMed ID: 33122944
[TBL] [Abstract][Full Text] [Related]
40. Comprehensive analysis of pyroptotic gene prognostic signatures associated with tumor immune microenvironment and genomic mutation in breast cancer.
Zhang H; Yu X; Yang J; He G; Zhang X; Wu X; Shen L; Zhou Y; Cheng X; Liu X; Zhu Y
Front Immunol; 2022; 13():933779. PubMed ID: 36090993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
